This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting.
Intraocular lens market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an ever-increasing baby boom aging population. There is a growing precision of cataract surgery. Safety of cataract surgical medical devices and lenses are primary market concerns. More advanced procedures are driving an increase in cataract surgery. Lower costs per surgery are driving an increase in cataract surgery.
Cataract surgical technology is evolving rapidly. Premium intraocular lenses (IOLs) introduced during the past decade and those still in the pipeline are raising patient's post-cataract visual expectations. Laser-assisted cataract surgery technology is gaining traction with clinicians.
Surgeons are getting trained in the techniques needed to perform surgeries these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision.
Susan Eustis, lead author of the WinterGreen Research team that prepared the Intraocular Lens (IOL) market research study, "Superior image quality brings clinical improvement. Patients are thrilled when they can see so much more clearly."
As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating IOLs designed to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and phakic IOLs allowing treatment of extreme refractive error.